CLINICAL TRIAL: ACTG A5229 TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY
CLINICAL TRIAL: ACTG A5229 TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY
批准号:
7724950
负责人:
DANIEL LEE
金额:
$1.98万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-11-30
关键词:
ClinicalClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDEXAFatty acid glycerol estersFundingGrantHIV-1InstitutionLimb structureLipoatrophyMeasuresPlacebosResearchResearch PersonnelResourcesSourceSupplementationUnited States National Institutes of HealthUpper armUridineWeek
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Examine the effect of uridine supplementation on limb fat in HIV-1 infected subjects with clinical lipoatrophy by comparing changes from baseline to week 48 in DEXA measured limb fat between the urdine arm and the placebo arm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: ACTG A5229 TRIAL OF URIDINE SUPPLEMENTATION IN HIV LIPOATROPHY
-
批准号:7950961
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2008
-
负责人:DANIEL LEE
-
依托单位:
FRAM 2 FAT REDISTRIBUTION & METABOLIC CHANGE IN HIV INFECTION
-
批准号:7606562
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2006
-
负责人:DANIEL LEE
-
依托单位:
海外基金